John P Davis1, Morgan Salmon1, Nicolas H Pope1, Guanyi Lu1, Gang Su1, Ashish K Sharma1, Gorav Ailawadi1, Gilbert R Upchurch2. 1. Division of Vascular and Endovascular Surgery and Cardiothoracic Surgery, Department of Surgery, University of Virginia School of Medicine, Charlottesville, Virginia. 2. Division of Vascular and Endovascular Surgery and Cardiothoracic Surgery, Department of Surgery, University of Virginia School of Medicine, Charlottesville, Virginia. Electronic address: GRU6N@hscmail.mcc.virginia.edu.
Abstract
BACKGROUND: No medical therapies are yet available to slow abdominal aortic aneurysm (AAA) growth. This study sought to investigate the effect of different genders of bone marrow-derived mesenchymal stem cells (MSC) on AAA growth in a murine AAA model. Given the decreased rate of AAA in women, it is hypothesized that female MSC would attenuate AAA growth more so than male MSC. MATERIALS AND METHODS: Aortas of 8-10-wk-old male C57Bl/6 mice were perfused with purified porcine pancreatic elastase to induce AAA formation. Bone marrow-derived MSC from male and female mice were dosed via tail vein injection (3 million cells per dose, 500 μL of volume per injection) on postaortic perfusion days 1, 3, and 5. Aortas were harvested after 14 d. RESULTS: Mean aortic dilation in the elastase group was 121 ± 5.2% (mean ± standard error of the mean), while male MSC inhibited AAA growth (87.8 ± 6.9%, P = 0.008) compared with that of elastase. Female MSC showed the most marked attenuation of AAA growth (75.2 ± 8.3% P = 0.0004). Proinflammatory cytokines tumor necrosis factor α, interleukin 1β, and monocyte chemotactic protein-1 (MCP-1) were only decreased in tissues treated with female MSC (P = 0.017, P = 0.001, and P < 0.0001, respectively, when compared with elastase). CONCLUSIONS: These data exhibit that female MSC more strongly attenuate AAA growth in the murine model. Furthermore, female MSC and male MSC inhibit proinflammatory cytokines at varying levels. The effects of MSC on aortic tissue offer a promising insight into biologic therapies for future medical treatment of AAAs in humans.
BACKGROUND: No medical therapies are yet available to slow abdominal aortic aneurysm (AAA) growth. This study sought to investigate the effect of different genders of bone marrow-derived mesenchymal stem cells (MSC) on AAA growth in a murineAAA model. Given the decreased rate of AAA in women, it is hypothesized that female MSC would attenuate AAA growth more so than male MSC. MATERIALS AND METHODS: Aortas of 8-10-wk-old male C57Bl/6 mice were perfused with purified porcine pancreatic elastase to induce AAA formation. Bone marrow-derived MSC from male and female mice were dosed via tail vein injection (3 million cells per dose, 500 μL of volume per injection) on postaortic perfusion days 1, 3, and 5. Aortas were harvested after 14 d. RESULTS: Mean aortic dilation in the elastase group was 121 ± 5.2% (mean ± standard error of the mean), while male MSC inhibited AAA growth (87.8 ± 6.9%, P = 0.008) compared with that of elastase. Female MSC showed the most marked attenuation of AAA growth (75.2 ± 8.3% P = 0.0004). Proinflammatory cytokines tumor necrosis factor α, interleukin 1β, and monocyte chemotactic protein-1 (MCP-1) were only decreased in tissues treated with female MSC (P = 0.017, P = 0.001, and P < 0.0001, respectively, when compared with elastase). CONCLUSIONS: These data exhibit that female MSC more strongly attenuate AAA growth in the murine model. Furthermore, female MSC and male MSC inhibit proinflammatory cytokines at varying levels. The effects of MSC on aortic tissue offer a promising insight into biologic therapies for future medical treatment of AAAs in humans.
Authors: Paul R Crisostomo; Meijing Wang; Christine M Herring; Eric D Morrell; Preethi Seshadri; Kirstan K Meldrum; Daniel R Meldrum Journal: Shock Date: 2006-12 Impact factor: 3.454
Authors: Paul R Crisostomo; Troy A Markel; Meijing Wang; Tim Lahm; Keith D Lillemoe; Daniel R Meldrum Journal: Surgery Date: 2007-08 Impact factor: 3.982
Authors: F A Lederle; G R Johnson; S E Wilson; E P Chute; R J Hye; M S Makaroun; G W Barone; D Bandyk; G L Moneta; R G Makhoul Journal: Arch Intern Med Date: 2000-05-22
Authors: F A Lederle; G R Johnson; S E Wilson; E P Chute; F N Littooy; D Bandyk; W C Krupski; G W Barone; C W Acher; D J Ballard Journal: Ann Intern Med Date: 1997-03-15 Impact factor: 25.391
Authors: M Carmo; L Colombo; A Bruno; F R M Corsi; L Roncoroni; M S Cuttin; F Radice; E Mussini; P G Settembrini Journal: Eur J Vasc Endovasc Surg Date: 2002-06 Impact factor: 7.069
Authors: Rachel K Middleton; Geraint M Lloyd; Matthew J Bown; Nicola J Cooper; Nicholas J London; Robert D Sayers Journal: J Vasc Surg Date: 2007-03 Impact factor: 4.268
Authors: Peggy Robinet; Dianna M Milewicz; Lisa A Cassis; Nicholas J Leeper; Hong S Lu; Jonathan D Smith Journal: Arterioscler Thromb Vasc Biol Date: 2018-01-04 Impact factor: 8.311
Authors: Ashish K Sharma; Morgan D Salmon; Guanyi Lu; Gang Su; Nicolas H Pope; Joseph R Smith; Mark L Weiss; Gilbert R Upchurch Journal: Arterioscler Thromb Vasc Biol Date: 2016-03-17 Impact factor: 8.311
Authors: Michael Spinosa; Guanyi Lu; Gang Su; Sai Vineela Bontha; Ricardo Gehrau; Morgan D Salmon; Joseph R Smith; Mark L Weiss; Valeria R Mas; Gilbert R Upchurch; Ashish K Sharma Journal: FASEB J Date: 2018-05-29 Impact factor: 5.191
Authors: Joscha Mulorz; Mahdis Shayan; Caroline Hu; Cynthia Alcazar; Alex H P Chan; Mason Briggs; Yan Wen; Ankita P Walvekar; Anand K Ramasubramanian; Joshua M Spin; Bertha Chen; Philip S Tsao; Ngan F Huang Journal: Biomater Sci Date: 2021-10-12 Impact factor: 7.590